For instance, higher levels of RHAMM have been noted as a marker for adverse outcomes in various cancers such as breast cancer [39,40,41], multiple myeloma [42], and others, ranging from oral squamous cell carcinoma [43] to gastric cancer [44]. The gene discussed is HMMR; the disease is breast carcinoma.